newsfilter
← Latest News
Business Wire·

Astria Stockholders Vote to Approve Acquisition by BioCryst

Astria Therapeutics, Inc. (NASDAQ:ATXS) today announced that at the special meeting of Astria's stockholders held on January 21, 2026, Astria's stockholders voted to approve the acquisition of Astria by BioCryst